Why CyberOptics Is Tuesday’s Biggest Loser

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Why CyberOptics Is Tuesday’s Biggest Loser

© Thinkstock

CyberOptics Corp. (NASDAQ: CYBE) was one of Tuesday’s biggest losers after the company said that its second-quarter and full-year 2019 operating results will be materially affected by the cyclical, industrywide slowdown in demand for surface mount technology (SMT) and semiconductor capital equipment and continued uncertainty in the global trade environment.

According to the firm, orders for SMT and semiconductor products started to weaken during the second quarter. Despite strong year-over-year sales of 3D MRS-enabled SQ3000 AOI inspection systems, CyberOptics is now forecasting sales of $15.0 million to $15.2 million for the second quarter ending June 30, which would be at the low end of its previously issued guidance of $15.0 million to $16.5 million for this period. Second-quarter operating results will include sales of $1.1 million for MX600 memory module inspection systems.

Looking ahead, the impact of weakness in the SMT and semiconductor markets is causing CyberOptics to forecast sales of $12.0 million to $13.5 million for the quarter ending in September. The company said it expects sluggish market conditions to persist in the fourth quarter of 2019 before strengthening in early 2020.

[nativounit]

CyberOptics is expected to report its quarterly results after the markets close on July 24. Consensus estimates are calling for $0.07 in earnings per share and $15.71 million in revenue for the fiscal second quarter.

Shares of CyberOptics were last seen down 18% at $14.67, in a 52-week range of $14.24 to $22.61. The consensus price target is $25.00.

[recirclink id=557940]
[wallst_email_signup]

Contact [email protected] for any questions or corrections.

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics. Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications. A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Our $500K AI Portfolio

See us invest in our favorite AI stock ideas for free

Our Investment Portfolio

Continue Reading

Top Gaining Stocks

META Vol: 40,760,422
KMX Vol: 2,288,021
WY Vol: 6,523,553
SBAC Vol: 1,443,801
NVDA Vol: 148,249,982

Top Losing Stocks

MRNA Vol: 9,176,778
CTRA Vol: 73,319,495
CRWD Vol: 9,269,567
DDOG Vol: 5,135,556
EPAM Vol: 1,164,561